KMCP-98 is a newly synthesized adenosine receptor agonist by alkylation at
the 7-position of the xanthines nucleus. We first investigated the pharmaco
logical activities of KMCP-98 under in vivo and in vitro conditions. Acute
intravenous injection of KMCP-98 (1.0, 2.0 and 3.0 mg/kg) produced a tempor
ary fall in blood pressure and heart rate, followed by a sustained fall in
heart rate in pentobarbital-anesthetized Wistar rats. The hypotensive and b
radycardiac responses were inhibited by pretreatment with an A(1) adenosine
receptor antagonist 8-phenyltheophylline (8-PT, 0.5 mg/kg). Both KMCP-98 a
nd adenosine (0.3 - 100 muM) produced negative inotropic activitity in isol
ated guinea pig left atria. The negative inotropic activity of KMCP-98 was
significantly blocked by pretreatment with A(1) receptor antagonists 8-PT (
10 muM) and xanthine amine congener (XAC, 10 muM), a nonselective adenosine
antagonist theophylline (10 muM), a K channel blocker tetraethylammonium (
TEA, 10 mm) and a K-ATP channel blocker glibenclamide (1 muM). KMCP-98 (0.0
3 - 30 muM) produced concentration-dependent relaxations in carbachol (1 mu
m) precontracted guinea pig tracheal smooth muscle. The trachea relaxant re
sponse of KMCP-98 was markedly inhibited by A(2), A(2a) and A(2b) adenosine
receptor antagonists 3,7-dimethyl-1-propargylxanthine (DMPX, 10 muM), 8-(3
-chlorostyryl)caffeine (CSC, 10 M) and alloxazine (10 [M), respectively, th
e nitric oxide synthase (NOS) inhibitor L-NAME (100 muM) and also by TEA an
d glibenclamide. In addition, KMCP-98 (0.03 - 30 muM) elicited relaxant res
ponse in norepinephrine (3 muM) precontracted rat thoracic aorta in a conce
ntration-dependent manner. The thoracic aorta relaxant response of KMCP-98
was also significantly inhibited by DMPX, CSC, alloxazine, L-NAME, TEA and
glibenclamide. Furthermore, the binding characteristics of KMCP-98, adenosi
ne and 5 ' -N-ethylcarboxaminoadenosine (NECA) were evaluated in [H-3]DPCPX
and [H-3]CGS 21680 binding to rat cortex and striatum, respectively. The K
-i values of KMCP-98 for predominate A(1) and A(2) adenosine receptor sites
were 3908 +/- 952 and 158 +/- 10 nM, respectively. In conclusion, KMCP-98
was found to be a xanthine-based adenosine receptor agonist associated card
iac depression, tracheal and aortic smooth muscle relaxations. (C) 2001 Els
evier Science Inc. All rights reserved.